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Abstract. As part of the EU Plastics Strategy, the European Commission has initiated the restriction pro-
cess regarding intentionally added microplastics under REACH (acronym of the EU chemical regulation).
A restriction dossier is compiled by ECHA according the provisions of REACH. Not only environmental
and health risk assessments have to be made, but a large part of the dossier concerns socio-economic analy-
ses and evaluations of risk management options, in order to justify a Union-wide restriction. The procedure
reﬂects the multiple objectives of REACH: protection of human health and the environment, but also the
functioning of the internal market. Although the precautionary principle is incorporated in REACH, it
plays a less than subordinate role. The process of restriction oﬀers interested parties the possibility to
present information and evidence. For the restriction dossier on microplastics is of utmost importance that
all available evidence is provided. When less data is available, restriction seems to be less likely.
1 Introduction
In November 2017, the European Commission requested the European Chemical Agency (ECHA) to prepare a restric-
tion dossier on microplastics, thereby starting the restriction procedure under REACH, the EU chemicals regulation [1,
2]. This decision follows the conclusion of a study on intentionally added microplastics, which was instigated by the
request of several Member States and commissioned in 2015 (EC Report on Microplastics) [3]. Moreover, national leg-
islation and proposals thereto, of France, Sweden and Belgium in 2016 and 2017, triggered the request for a restriction
dossier. The EU Plastics Strategy, published in January 2018, further built up the momentum for the regulation of
plastics in general [4]. This article looks into the process and steps of the restriction process under REACH, in partic-
ular on restricting microplastics in cosmetics products, as it will be most likely that, at least, this restriction measure
will be proposed. Although covering only a limited fraction of the intentionally added microplastics, microplastics
in cosmetic products are relatively easy to phase out and are already regulated by national measures. However, the
request for a restriction dossier and the EC Report on Microplastics go beyond microplastics in cosmetic products, as
environmental hazards of other products with microplastics are likely to be the same. Besides, microplastics emitted
in the environment, not intentionally added, but generated during the life cycle of product, likewise form a threat to
the environment, a matter also under attention of the European Commission [5].
This article is written from a law-making perspective and its purpose is to provide scientists with a better un-
derstanding how EU law-making works, in particular in the case of restricting microplastics. The interaction between
scientiﬁc evidence and policy-making is, of course, not a new phenomenon, and scientiﬁc research has invoked policy
change in the past [6]. This article addresses in particular the REACH restriction procedure. The input of science
is institutionalised by the creation of scientiﬁc committees, in particular the Committee for Risk Assessment and
the Committee for Socio-economic Analysis. Also scientiﬁc studies are extensively used for compiling the restriction
dossier. It points out the interaction between policy making and science: without scientiﬁc evidence no restriction in
REACH can be adopted. But, as the article also establishes, the ﬁnal decision remains in political hands.
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2 REACH regulation
REACH is the chemical regulations of the European Unions (EU) adopted in 2006 and regulates the registration,
evaluation, authorisation and restriction of chemical substances. According to Article 1 REACH, its aims are protection
of human health and environment and internal market and its provisions are underpinned by the precautionary
principle. REACH replaces the rather ad-hoc approach of previous EU regulation on chemicals, which was based on
responding on problems that emerged [7]. REACH is complemented by the Regulation on the classiﬁcation, labelling
and packaging of substances (CLP Regulation) [8].
The building blocks of REACH are the procedures of registration, evaluation, authorisation and restriction. A
substance can only enter the EU market when is has been registered by the manufacturer or importer, the so-called
“no data, no market” rule, included in Article 5 REACH. The manufacturer or importer of a substance has to submit a
technical dossier for registration according Article 10 REACH, the registration dossier. Polymers have been exempted
according from this rule according Article 6.3 REACH, if its monomers substances have been registered.
Evaluation pertains to dossier and substance evaluation. There are two types of dossier evaluations: the examination
of testing proposals for conducting tests on vertebrate animals to prevent unnecessary testing, and the compliance
check of at least 5% of registration dossiers. Substance evaluation will be carried out by Member States after placing
the substance on a priority list, based on risk and hazards, as deﬁned by Article 44 REACH. The results of substance
evaluation can lead to further regulatory steps, such as authorisation, restriction, voluntary actions or measures under
other EU legislation.
The authorisation procedure can be started when a substance is listed or marked as a substance of very high concern
(SVHC). Generally, this is the case if a substance can be classiﬁed as carcinogenic, mutagenic or toxic for reproduction
(CMRs), or as persistent, bioaccumulative and toxic (PBT), or as very persistent and very bioaccumulative (vPvB)
or for which equivalent concerns exist (Article 57 REACH). The authorisation procedure is aiming at substituting
these substances with less dangerous alternatives, in subsequent phases. After the so-called sunset date, the use of
the substance has to be authorised by the European Commission, which can be done under certain conditions and
until further review. Authorisation does not apply to substances in products and would therefore not be suitable for
regulating microplastics in certain products [9].
Restriction of a substance is initiated when there is an unacceptable risk to human health or the environment, arising
from the manufacture, use or placing on the market of substances, which needs to be addressed on a Community-wide
basis (Article 68 REACH). In that case, Annex XVII REACH, listing all restrictions, will be amended according to
the restriction process and legislative procedure described further in this article.
REACH provides for several exemptions, which can be general or partial. Certain substances can be exempted
from certain procedures, such as registration, or REACH may not be applicable to certain products or in certain
cases. Regarding microplastics, it is important to note that polymers, as substances are completely exempted from
registration and evaluation, if its building blocks, monomers, have been registered according Article 6.3 REACH [10].
At the time of adopting REACH, in several jurisdictions, such as the US and Japan, the concept of polymers of low
concern was used to reduce regulatory requirements for the majority of polymers [11]. Although the approach of
REACH is totally diﬀerent from those in these jurisdictions —in particular the pre-registration requirement for any
substance, harmful or not—, a general exemption for polymers was incorporated. To end this exemption and to bring
polymers under the registration regime, the European Commission may initiate a speciﬁc procedure of Article 138
REACH: the Commission ﬁrst has to compile a report on the risks of polymers and the need for registration, and then
it may, if there is a practical and cost-eﬃcient way of selecting polymers, propose an amendment to include polymers
for registration.
Other exceptions are based on overlap with other regulations. This is the case regarding microplastics in cosmetic
products: also the Cosmetics Regulation applies [12]. The Cosmetic Regulation regulates the safety for human health
of cosmetic products when used under normal or reasonably foreseeable conditions of use, as stated in Article 3 of the
Cosmetics Regulation. Consequently, the restriction of substances in cosmetic products for human health concerns
is exclusively regulated by the Cosmetics Regulation and the restriction process of REACH is only applicable to
environmental concerns or to indirect human health concerns (Article 67.2 REACH).
3 Actors involved in the restriction process
The restriction process involves several actors, which all have a speciﬁc tasks and roles during the process. The mi-
croplastics restriction process started with a preparatory study in intentionally added microplastics by the Commission
on request of the Member States, the EU Report on Microplastics. Both Member States and the Commission can take
the initiative to prepare a restriction dossier, and in case the Commission is the initiator, ECHA has to prepare it. In
the microplastics restriction process, ECHA has a leading role as compiler of the dossier, also called the restriction
report.
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After the submission of the restriction dossier, the Committee for Risk Assessment (RA Committee) and the
Committee for Socio-economic Analysis (SEA Committee) come into play. These committees check conformity of the
dossier and give an opinion on the proposed restriction. The RA Committee consists of one or two member(s) of each
EU Member State and currently includes 54 experts in ﬁelds such as (eco)toxicology, chemistry, and risk assessment
(Article 85 REACH) [13]. Also the SEA Committee consists of one or two member(s) of each Member State and,
at present, counts 36 members, with experts in the same ﬁelds as the RA Committee, complemented with experts
in economics and law. Members of both committees are appointed by ECHA based on nominations of the Member
States. There is also a small role for the Forum for Exchange of Information on Enforcement (Forum), composed
of representatives of the Member States, which coordinates a network of Member States authorities responsible for
enforcement of REACH. The Forum examines restriction proposals and gives an advice concerning enforceability
(Article 77.4.h REACH).
In diﬀerent stages of the process, interested parties will be asked to provide comments and evidence. Interested
parties are, according to ECHA, citizens, organisations, companies as well as authorities of Member States. Manufac-
turers or importers of substances do not have a particular role in the restriction process and are treated as interested
parties. After the publication of the registration dossier, the formal public consultation period starts, but also in the
period of the preparation of the restriction report interested parties may be called upon to provide information.
The Commission has the task to prepare a decision on restriction and has the leading role in the legislative part,
the regulatory procedure with scrutiny (Article 133.4 REACH) [14]. If so decided, it will draft the amendment to
REACH, based on the proposal in the restriction report. A Scrutiny Committee, composed of representatives of the
Member States, will give its opinion, and the draft amendment will be sent for voting to the European Parliament
and the Council of the European Union, consisting of the relevant ministers of the Member States. After adoption of
the restriction, the Member States are responsible for the enforcement of REACH.
4 The restriction process
The restriction process formally starts with a notiﬁcation of intention of a Member State, a request of the Commission,
or when ECHA decides itself after authorisation, to prepare a restriction dossier. ECHA listed the intention of submis-
sion of the restriction report on microplastics on 17 January 2018 after the request of the Commission to prepare such
dossier on 9 November 2017. The listing of the notiﬁcation by ECHA on 17 January 2018 should be considered as the
date of the start of the restriction process on microplastics, as outlined in table 1. According to Article 69 REACH,
within 12 months of the notiﬁcation the restriction report should be submitted and published. For the restriction
dossier on microplastics ECHA has set the date on 11 January 2019 for submission of the report. ECHA also made
a call for comments and evidence on 1 March 2018, ending on 11 May 2018 [15]. During this period all interested
parties are able to provide information on all possible intentional uses of microplastic particles in products in order to
determine whether these uses pose a risk. This consultation does not replace the formal public consultation after the
submission of the restriction report, but will help ECHA to develop the report and allows interested parties to signal
their interest and express their views and concerns.
After submission of the restriction report, expected on 11 January 2019, the Committee for Risk Assessment
(RA Committee) and the Committee for Socio-economic Analysis (SEA Committee) will check the restriction dossier
on conformity with Annex XV REACH. Annex XV REACH includes the requirements of the registration dossier,
including a proposal for restriction, which will be discussed in the next part. The checks should be done within 30
days, but if the dossier does not conform, an additional 15 days will be given to the committees for stating the reasons
for non-conformity. Subsequently, the submitter is given 60 days to bring the restriction dossier in conformity with
the requirements of Annex XV REACH. As the microplastics report is prepared by ECHA, it would be unlikely
that it would not conform to its own standards. When the restriction report is considered conforming Annex XV
REACH, ECHA will publish the report on its website. This date, for the microplastics report can be expected between
11 January 2019 —the announced date of submission— and 3 May 2019 —the latest date for submission of the
restriction dossier in conformity with Annex XV REACH.
The publication date is a new benchmark in the restriction procedure, as it is the start of several simultaneous
steps in the procedure. Both the RA Committee and SEA Committee will begin with the formulation of an opinion
regarding the proposed restriction, and also the 6-month period of public consultation starts. The RA Committee
should ﬁnalise its opinion within nine months, while the SEA Committee should ﬁrst prepare a draft opinion. The
draft opinion is published and interested parties are invited to give their comments within 60 days. The ﬁnal opinion of
the SEA Committee should be adopted within 12 months of the publication date of the restriction dossier, in case of no
delays that would be 11 January 2020. ECHA will publish the committee opinions, advice of the Forum, the comments
received through public consultation as well as the response to the comments by the submitter of the restriction dossier
and the committees. The Commission will then prepare its decision on the restriction dossier within three months and,
if so decided, draft the amendment to Annex XVII REACH to include the restriction. For the microplastics dossier,
the anticipated date would be 11 April 2020. The regulatory procedure with scrutiny will then start. The Scrutiny
Committee delivers its opinion on the draft amendment, within a time-limit, laid down by the chair of the Committee.
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Table 2. Format of a restriction dossier.
Report Annexes
Summary
1) The problem identiﬁed Annex A. Manufacture and uses
Annex B. Information on hazard, exposure/emissions and risk
Annex C. Justiﬁcation for action on a Union-wide basis
Annex D. Baseline
2) Impact assessment Annex E. Impact Assessment
3) Assumptions, uncertainties and sensitivities Annex F. Assumptions, uncertainties and sensitivities
4) Conclusion
Annex G. Stakeholder information
Then, the European Parliament and the Council will come in. There are diﬀerent scenarios depending whether
the draft measure is in accordance with opinion of the Scrutiny Committee or not [14]. At best, the Commission may
adopt the draft amendment within three months if there is no opposition of the Council or European Parliament.
But if there is opposition and/or the opinion of the Scrutiny Committee is not in accordance, majority voting in
the Council and European Parliament is required, and if the proposed restriction is opposed, an amended proposal
should be submitted by the Commission, and the regulatory procedure with scrutiny will be repeated. Therefore, it is
impossible to predict when a restriction on microplastics may come into force.
5 Restriction dossier on intentionally added microplastics
The content of a restriction dossier is outlined in Annex XV of REACH. The dossier should consist information on six
parts: proposal, information on hazard and risk, information on alternatives, justiﬁcation for restrictions at Community
level, socio-economic assessment, and information on stakeholder consultation. ECHA has published a guidance, which
provides hands-on information for submitters of a restriction dossier, but also for interested parties [16]. The format
of a restriction dossier has been updated in 2016 to provide a new structure and a rearrangement of the required
information [17]. In the new format, the dossier includes a “report” containing the restriction proposal and supporting
information, while detailed information is provided in “annexes”, as outlined in table 2.
5.1 Summary
The cover page includes the chemical name of the substance(s), the IUPAC name(s), the EC number(s)1, and CAS
number(s) if applicable. The summary introduces the scope and conditions of the restriction and includes the restriction
proposed and a summary of the justiﬁcation, based on the information provided in the subsequent parts of the
restriction dossier. The proposed restriction is composed according to the table in Annex XVII REACH on restrictions
and can directly be used as text for the amendment. However, if ECHA concludes that there is no need for a proposed
restriction, this part explains why no restriction is proposed2.
5.2 The problem identiﬁed
This section starts with the hazard, exposure/emissions and risks, based on the information given in Annex A and B of
the report. Providing the identity information of the substance(s), Annex B starts with information on the molecular
and structural formula and the composition of the substance. It also includes a justiﬁcation for grouping in case the
restriction proposal covers more than one substance.
1 The EC number is the number which has been given in the EC Inventory, a combination of three lists under former European
regulations: the European Inventory of Existing Commercial Chemical Substances (EINECS), the European List of Notiﬁed
Chemical Substances (ELINCS) and the No-Longer Polymers (NLP) list, see ECHA, https://echa.europa.eu/information-
on-chemicals/ec-inventory.
2 See, for example, the Annex XV reports on Grill lighters ﬂuids and fuels for decorative lamps, labelled R65 or H304 (17
April 2015) and cadmium and its compounds (02 February 2015).
Page 6 of 12 Eur. Phys. J. Plus (2018) 133: 425
The European Commission has identiﬁed more than 130 synthetic polymers that may be added as microplastics to
products [3] and the ﬁrst challenge is to determine the deﬁnition of microplastics for restriction. Although there may
be various ways to make distinctions, such as diﬀerentiating between homopolymers and copolymers, and types of
polymers [18], the discussion on deﬁnitions suggests, that, regarding microplastics in cosmetic products, a distinction
between functions, solid and not solid, and solubility in water can be made. Guidance within REACH can be found
in Annex XI of REACH, providing that the physicochemical, toxicological and ecotoxicological properties are likely to
be similar or follow a regular pattern as a result of structural similarity. For grouping REACH requires that those
properties and human health and environmental eﬀects or fate may be predicted from data for reference substance(s)
within the group by interpolation to other substances in the group, the read-across approach. Grouping is also possible
for related substances if the key property in combination with the exposure that causes the risk leading to the restriction
proposal is shared by those related substances [16].
Since the compiling of the restriction dossier is triggered by national initiatives, in particular the French prohibition,
a look at the deﬁnition of the substance in this regulation is justiﬁed. The French legislation does not refer to speciﬁc
substances but deﬁnes microplastics as “particules plastiques solides, a` l’exception des particules d’origine naturelle
non susceptibles de subsister dans les milieux, d’y propager des principes actifs chimiques ou biologiques ou d’aﬀecter
les chaˆınes trophiques animales”, in English “solid plastic particles, with the exception of particles of natural origin
not liable to persist in the environment, release active chemical or biological ingredients thereinto, or aﬀect animal
food chains” [19]. This deﬁnition in turn was based on the deﬁnition of the US Microbead-Free Waters Act of 2015,
which deﬁnes a microbead as any solid plastic particle that is less than ﬁve millimeters in size and is intended to be
used to exfoliate or cleanse the human body or any part thereof [20]. These deﬁnitions more or less group all solid
synthetic polymers. The French deﬁnition explicitly excludes polymers of natural origin, with the condition that these
are not harmful for the environment. The US deﬁnition, though, includes the function of the microplastics: exfoliating
and cleansing, excluding microplastics that have other functions. In literature, microplastics are deﬁned as synthetic,
nondegradable, water insoluble, solid materials made up of polymers. They are often made of petroleum carbons
source and a distinction can be made between thermoplastics and thermoset plastics, and between homopolymers and
copolymers [21,22]. It is noted that cosmetics products also may include synthetic polymers that are liquid at ambient
temperature or water soluble, but these substances are generally not considered as microplastics [3]. Regarding the
functions, microplastics are added for exfoliating and cleansing, but also for ﬁlm formation, viscosity regulation, skin
conditioning, emulsion stabilizing, opacifying, bulking, glittering, functions that go beyond the US deﬁnition [3,22].
The EC Report on Microplastics established the following working deﬁnition:
– Microplastics consist of man-made, conventional plastics.
– Microplastics also include bio-degradable plastics, bio-based analogue plastics, and biobased alternative plastics.
– Microplastics are solid and water-insoluble particles.
– Microplastics have particle size below 5mm and include nanometer sized plastics as well (nanoparticles).
Through the exemption of polymers from registration, REACH has more or less “grouped” polymers. The exemp-
tion has also resulted in the fact that not all polymers have an EC number and information on polymers is limited
within the REACH system. For example, a frequent used type of microplastic in cosmetic products is Acrylates
Copolymer, which is a group of polymers containing monomers acrylic acid or methacrylic acid or one of their salts
or esters [23]. As an ingredient for cosmetic products, Acrylates Copolymer is included in CosIng, the EC Cosmetic
ingredient database for information on substances and ingredients [24]. The ﬁle for Acrylates Copolymer in CosIng
speciﬁes three CAS numbers and IUPAC names, while the US Cosmetic Ingredient Review on Acrylates Copolymer
includes over thirty groups of Acrylates Copolymer3. Since Acrylates Copolymer has no EC number, no information
regarding molecular formula and composition is available in the EC Inventory4.
Annex B follows the Chemical Safety Report (CSR) format, described in Annex I of REACH. This Annex sets
the requirements for assessment of hazard and risk assessments and provides a format for compiling a CSR. It should
also include substance identiﬁcation parameters, which are regulated in Article 10 of REACH, setting the information
standards for registration. As polymers are exempted from registration, the information for the microplastics dossier
3 25133-97-5 / 25035-69-2 / 25212-88-8, 2-propenoic acid, 2-methyl-, polymer with ethyl 2-propenoate and methyl 2-methyl-
2-propenoate, see CosIng, http://ec.europa.eu/growth/tools-databases/cosing/index.cfm; Cosmetic Ingredient Review,
Final report of the safety assessment of acrylates copolymer and 33 related cosmetic ingredients, in International Journal of
Toxicology, Vol. 21 (2002) p. 1; https://www.cir-safety.org/ingredients. The US Cosmetic Ingredient Review, an initiative
of the Personal Care Products Council, an industry trade association, carried out a review of Acrylates Copolymer in 2002,
and is currently working on an update. Registration of ingredients is totally voluntary in the US and it is the responsibility
of the manufacturer to ensure that cosmetic products are safe. See further: Cosmetic Ingredient Review Procedures, October
2010, http://www.cir-safety.org/sites/default/files/pdf1.pdf; U.S. Food & Drug Administration, Voluntary Cosmetic
Registration Program, https://www.fda.gov/Cosmetics/RegistrationProgram/default.htm.
4 EC Inventory, https://echa.europa.eu/information-on-chemicals/ec-inventory (search for Acrylates Copolymer gives
no results).
Eur. Phys. J. Plus (2018) 133: 425 Page 7 of 12
Table 3. Criteria for persistence according REACH Annex XIII as part of PBT/vPvB criteria.
Compartment Persistent: half-life days Very persistent: half-life days
Marine water > 60 days > 60 days
Fresh or estuarine water > 40 days > 60 days
Marine sediment > 180 days > 180 days
Fresh or estuarine water sediment > 120 days > 180 days
Soil > 120 days > 180 days
Table 4. Criteria for bioaccumulation according REACH Annex XIII as part of PBT/vPvB criteria.
Bioaccumulative Very bioaccumulative
Bioconcentration factor in aquatic species > 2000 > 5000
should be collected from other sources, such as safety data sheets. Chemical Safety Reports may be compiled for a group
of substances, based on the same criteria used for the identiﬁcation of substances as discussed above. Often an overview
of studies in literature will be presented, especially when no or limited information is presented by manufacturers in
registration dossiers and safety data sheets. Manufacturers and importers of substances, including polymers, have to
provide downstream users with a safety data sheet if the substance can be classiﬁed as hazardous under the CLP
Regulation, as a PBT or a vPvB, or when it is on the list for authorisation (Article 31 REACH). However, these are
not publicly available and the accuracy is the sole responsibility of the manufacturer or importer. A CSR includes ten
sections: 1) identity of the substance; 2) manufacture and uses; 3) classiﬁcation and labelling; 4) environmental fate
properties; 5) human health hazard assessment; 6) human health hazard assessment of physicochemical properties; 7)
environmental hazard assessment; 8) PBT and vPvB assessment; 9) exposure assessment; and 10) risk characterisation.
1) Information on the identity of the substance, including physical and chemical properties should be provided. Issues
regarding the identiﬁcation of microplastics, such as the possibility of grouping, have been discussed above.
2) Information on manufacture and uses is based on Annex A of the restriction dossier. Annex A should identify
quantity of manufacture and uses of the substances, on its own, in products and mixtures, and also include the
uses advised against. The EC Report on Microplastics provides detailed information on the use of microplastics in
cosmetic products, but only limited data on microplastics in other products, such as paints and coating, detergents,
and other uses. This part can be supplemented with information from interested parties, such as manufacturers
and downstream users, but also scientists.
3) If the substance is listed according the CLP Regulation, it should be noted in the section on classiﬁcation and la-
belling. A quick review shows that not many polymers have been classiﬁed or labelled. Also, the previous mentioned
frequently used microplastic Acrylates Copolymer is not listed.
4) The environmental fate properties must be described. Environmental fate properties that should at least be as-
sessed include degradation (abiotic degradation, biodegradation), environmental distribution, bioaccumulation and
secondary poisoning, including contamination of the food chain. Practice shows that these properties can be com-
plemented with other properties or more detailed properties if appropriate. The scientiﬁc research on these topics
should be reviewed in this part.
5) Human health hazard assessment is comprised of 11 properties: toxicokinetics (absorption, metabolism, distribution,
elimination), acute toxicity, irritation, corrosivity, sensitisation, repeated dose toxicity, germ cell mutagenicity,
carcinogenicity, toxicity for reproduction, other eﬀects, derivation of DNEL). It should be noted that the restriction
procedure on microplastics cannot apply to human health risks resulting from the normal use of cosmetics, and
that these issues should be addressed through the Cosmetics Regulation.
6) The human health hazard assessment of physicochemical properties consists of explosivity, ﬂammability and oxi-
dising potential.
7) Environmental hazard assessment considers the potential eﬀects on the environment, in particular the aquatic com-
partment, terrestrial compartment, atmospheric compartment and the microbiological activity in sewage treatment
systems. It should identify the concentration of the substance below which adverse eﬀects in the environment are
not expected to occur, the Predicted No-Eﬀect Concentration (PNEC). In the EC study on intentionally added
microplastics, the authors distinguish physical and toxic eﬀects. The assessment is wholly based on literature re-
view and comes to some cautious conclusion that there is some evidence for the potential for toxic eﬀects as well
as physical eﬀects to be exhibited on exposure of environmental organisms to microplastics [3]. It also points out
that is it not possible to establish a PNEC at this stage, due to the diﬀerent parameters used in studies and the
wide range of eﬀects.
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8) The objective of the PBT and vPvB assessment is to determine whether a substance is persistent, bioaccumulative
and toxic, or very persistent and very bioaccumulative according to the criteria in Annex XIII REACH. A substance
is persistent or very persistent if it fulﬁls any of the half-life values in table 3. Table 4 presents the criteria for
bioaccumulation. Further details can be found in Annex XIII REACH. Also in this part of the dossier, scientiﬁc
evidence should be reviewed.
9) According to Annex I REACH, the exposure assessment requires a quantitative or qualitative estimate of the
dose/concentration of the substance to which humans and the environment are or may be exposed. The assessment
should consider all stages of the life-cycle of the substance resulting from the manufacture and identiﬁed uses and
should cover any exposures that may relate to the hazards identiﬁed just above. Two steps can be distinguished:
development of exposure scenarios and exposure estimation.
The EC Report on Microplastics states that an approach to exposure estimate using EUSES (European Union
System for the Evaluation of Substances) represented a practicable and understandable method as the model is
well understood by European regulatory authorities and industry experts alike, and that it can be reasonably easily
adapted for estimation of the environmental distribution of microbeads for this project [3]. The report concludes
that, notwithstanding uncertainties, certain uses of microplastics appear to lead to notable concentrations in
environmental compartments, though it would be impossible to say whether these are signiﬁcant in terms of
environmental impact. As pointed out above, interested parties are able to provide ECHA with relevant information.
This section should also include an assessment of the risk management measures, including any existing legal re-
quirements, and the eﬀectiveness thereof. Included should be national measures, voluntary agreements and interna-
tional initiatives. Most obvious in relation to microplastics in cosmetic products is the prohibition of microplastics
as emission from cosmetics products cannot be prevented, though the ECHA Guidance for restriction dossiers
suggests a broad approach to provide the essential information for the section on justiﬁcation for restrictions at
Community level, which will be examined below. For microplastics in other products other measures could be ap-
propriate to prevent emission to the environment. Regarding microplastics in cosmetic products in the EU, so far
only the French legislation has taken eﬀect on the use of microplastics in cosmetic products by consumers, though
its ban is based on a limited deﬁnition applicable to only rinse-oﬀ products. The EC Report on Microplastics
suggests a decrease due to voluntary action taken by the cosmetics industry. However, part of these analyses is
based on research by Cosmetics Europe in 2012 [25], which was only surveying polyethylene microplastics used for
exfoliating and scrubbing, leaving out all other microplastics with other functions. The suggested decrease could
be explained by using alternative polymers, which were not included in the survey. On the international level,
the United Nations Environment Programme, in the Draft resolution on marine litter and microplastics [26], has
acknowledged microplastics as a serious threat to the environment and calls upon international organisation, states,
the private sector and civil society to take action.
10) The information on risk characterisation is closely related to the exposure assessment as it requires a risk character-
isation for each exposure scenario. It shall consider the human population (as workers, consumers or indirectly via
the environment). For microplastics, direct exposure to substances in cosmetic products is excluded from restriction
under REACH, however indirect exposure via contamination in water and food should be taken into account.
The practice of restriction dossiers demonstrates that the information in this part of the dossier can be based on
extensive literature review and information of interested parties. ECHA has made a call to provide evidence and
information on the intentional uses of microplastic particles in products of any kind [15]. ECHA stipulates that
the scope of the investigation is very wide and that all relevant products, including rinse-oﬀ and leave-on cosmetic
products will be investigated.
The justiﬁcation for an EU wide restriction measure should also be included in this part, requiring that i) action
is required on a union-wide basis, and ii) a restriction is the most appropriate community-wide measure with
regard to eﬀectiveness, practicality, and monitorability, with further details in Annex C. The restriction should be
considered against the objectives of REACH, human health and environment protection, as well as free circulation
of substances on the internal market. For the restriction dossier on microplastics, focus will be foremost on
environmental aspects, since the threat to the aquatic environment was identiﬁed as the main concern by the
European Commission. Both in the marine environment as in freshwater systems, microplastics are a major
source of pollution [27,28]. Oceans, rivers and lakes transport microplastics, even to the most remote areas of
the earth. The transboundary exposure to microplastics is a consideration for action on a union-wide base, which
should lead to a substantial reduction of intentionally added microplastics. Since removing microplastics from
the aquatic environment is extremely diﬃcult and costly, or even impossible, prevention is identiﬁed as the most
eﬀective option [29]. Acknowledgement of the fact that intentionally added microplastics are only a fraction of
all emitted microplastics to the environment, a restriction might nevertheless eﬀectively tackle this particular
fraction, notwithstanding the need for regulation on other emitted microplastics.
This section continues with considerations regarding the working of the internal market, as the restriction pertains
to the adding of microplastics to products, which are subject to the free movement of goods principle. In Article
9 of the Cosmetic Regulation, on free movement, it is stipulated that member states shall not restrict cosmetic
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products which comply with the requirements. Also REACH includes a roughly similar provision in Article 128.
The free movement of goods is a pillar of the European Union and prohibits unjustiﬁed restrictions by member
states. At the same time, it is the underlying principle of harmonisation of technical standards as key component
in EU law. This is conﬁrmed in case law regarding REACH, in which the Court stated that harmonisation is
a result from a ﬁnalised restriction process [30]. The Court also pointed out that national measures trigger the
restriction procedure, in order to harmonise standards. In its request for a restriction proposal, the European
Commission referred to national initiatives banning the use of microplastics and these circumstances contribute
to the justiﬁcation of a restriction on union level. Without harmonised standards, in the form of a restriction,
member states would be able to institute their own restrictions, possibly leading to a patchwork of standards.
The third section in this part of the report should contain information on the baseline, the business as usual
scenario, further detailed in Annex D, which may be used for the next part of the report, the impact assessment.
5.3 Impact assessment
This part of the dossier should provide information on all potential impacts, with a qualitative and quantitative
assessment of the impacts, and monetisation thereof. Annex E provides the detailed information and the ﬁrst section
deals with the risk management options (RMOs). RMOs are any possible changes to legislation or other requirements
to industry to control risks, including the proposed restriction but also, for example, other restrictions based on other
regulation, and economic instruments and voluntary agreements. The second section describes alternative substances.
Annex XV prescribes that available information on alternative substances and techniques shall be provided, including:
– information on the risk to human health and the environment related to the manufacture or use of the alternatives,
– availability, including the time scale, and, – technical and economical feasibility.
Annex E also contains a description of restriction scenarios, economic impacts, human health and environmental
impacts, and other impacts, such as social impacts and wider economic impacts, which can be seen as a socio-economic
assessment as required by Annex XV REACH. This section of the dossier has been labelled as an enormous diﬃcult
task [31]. The restriction report expects a description of at least two restriction options, which are assessed and
compared in detail.
The EC Report on Microplastics includes a twenty-page review of alternatives in a wide range of products. For
microplastics in cosmetic products, focus is on scrub and exfoliating functions, however the report notes that widening
of the deﬁnition and the scope of restriction may lead to thousands of alternatives to be assessed. Two scenarios of
restrictions, based on diﬀerent deﬁnitions of microplastics, are put forward. Scenario 1 is based on the restriction of
microplastics as a solid, no soluble plastic particle, both in rinse-oﬀ and leave-on products. Based on information from
Cosmetic Europe and the European Federation for Cosmetic Ingredients (EFfCI), the EC Study concludes that this
scale of costs is unlikely to be aﬀordable.
Scenario 2 would involve a restriction covering all polymers. Based on information provided by EFfCI, it would
follow that virtually all classes of cosmetic products would be aﬀected. According to the industry, most formulations
would no longer be feasible, while alternative technologies are not available and would take years/decades to develop (if
at all possible). Financial information is mostly based on calculations of the industry, in particular the reformulation
costs of products, and costs are estimated in the worst case at some¤ 5.2 billion annually. Although taking into account
variabilities and uncertainties, the EC Report on Microplastics points out that the potential costs of a restriction are
potentially very signiﬁcant. The report concludes that it is not considered possible to demonstrate that the net beneﬁts
of a restriction to health and the environment would outweigh the net costs to the industry and consumers at the
present time [3].
Conclusions in the impact assessment chapter are used in developing the justiﬁcation that the proposed restriction
is the most appropriate measure, especially in the light of eﬀectiveness and practicality. Which assessment weights
more is unclear, though the hierarchy will determine largely the conclusions on justiﬁcation [31]. The information
also provides a basis for the opinion of the SEA Committee. Therefore, it is essential that further information from
interested parties is presented, which may complement the information or even counter the assumptions in the EC
Report on Microplastics. For example, there are already more than ﬁfty cosmetic companies that do not use microplastic
ingredients in all of their products [32], proving that there are readily available alternatives for competitive prices,
which may reduce the reformulation costs signiﬁcantly.
5.4 Assumptions, uncertainties and sensitivities
In this chapter of the restriction report the main assumptions should be described, as well as the uncertainties.
Uncertainties can be noted in all kinds of information, from quantities in use and of emissions, to estimates and
calculation of costs. As we have seen in the previous chapter, if only information of one particular source is available,
assessments will be largely based on this information, and therefore could be incomplete or even biased. This part
could also indicate a request for further information from stakeholders to test assumptions or reduce uncertainties.
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A gap in scientiﬁc data may also trigger the application of the precautionary principle. Its purpose is to make greater
allowance for uncertainty and it may result in a shift of the burden of proof [33,34]. However, no mentioning of the pre-
cautionary principle is made in any of the guidance documents of ECHA. A review of restriction dossiers reveals that the
precautionary principle does not play a role in the assessment and justiﬁcation of restrictions. It seems to be a missed
opportunity and may possible prevent restrictions in situations of uncertainty [34]. Regarding the certain uses on mi-
croplastics, the EC Report on Microplastics concludes that for the use of microplastics in the oil and gas industry, hardly
any scientiﬁc data is available [3]. No further analyses of these uses are made in the report, and it seems unlikely that
a restriction would cover these uses, while the potential of contamination of these uses may be as severe as other uses.
5.5 Conclusion and information on stakeholder consultation
The report ends with a conclusion stating shortly the proposed restriction and the justiﬁcations. Annex G in the
Annexes part refers to stakeholder contacts, and the methods employed, ranging from calls for evidence to direct
consultation and participation in meetings. This pertains to informal consultation, as the formal consultation starts
after the submission of the restriction dossier.
As mentioned above, ECHA made a call for evidence and information regarding the restriction dossier and ECHA
particular welcomed information on the deﬁnition of microplastics, the speciﬁc uses, the functions, the alternatives and
socio-economic impacts. Furthermore, it asked for information on analytical methods for detecting and characterising
microplastic particles in products.
Compiling a restriction dossier according to the requirements described above, is a time-consuming and complex
task. Guidance is provided by ECHA, but as result of the large quantity of information to supply and the details
required, it seems almost impossible to collect and assess the information within a year. Practically, the European
Commission has stretched this period regarding the restriction dossier on microplastics by ﬁrst commissioning a study
with similar sections, which resulted in the EC Report on Microplastics. Nevertheless, it remains a daunting task
to prepare a restriction dossier on microplastics, given the number of polymers, the lack of registration dossiers,
the various functions and uses of microplastics, the numerous products that contain microplastics, great quantity
of dispersed scientiﬁc information, and the number of required assessments, in particular hazard, impact, risk and
socio-economic assessments.
6 Furthers steps in the restriction procedure
As outlined above, after submitting the restriction dossier, both the SEA and RAC Committees prepare an opinion,
and interested parties are able to provide comments. At any time, the European Commission is able to withdraw
the restriction proposal. After this period it is up to the European Commission to draft the amendment for inclusion
of a restriction in Annex XVII of REACH, and guide it through the regulatory procedure. When a restriction is
adopted and published, usually a phase out period will start, so industry can adjust its substances and products for
compliance. Enforcement is a task for member states. Each member state should implement the REACH restriction
into its national legislation and set sanctions for non-compliance. National authorities may carry out inspections, which
could be coordinated and guidance of ECHA. However, the main responsibilities are with the national authorities, as
ECHA has not enforcement powers.
Restrictions may be amended, through the same procedure, so by compiling again a restriction dossier. Also
provisional measures may be taken in case of urgent action is essential to protect human health or the environment
(Article 129 REACH), which would trigger the restriction procedure for amendment.
Concluding remarks
This article has attempted to describe the restriction process and the contents of the restriction dossier, while addressing
the issue of scientiﬁc input. The procedure is complex and lengthy, with several consultations of interested parties in
diﬀerent phases. Scientiﬁc experts are able to provide evidence in both informal and formal positions, as interested
parties, but also as members of the RA or SEA Committees.
Although following an outlined format and guidance by ECHA, the compilation of a restriction dossier remains an
enormous task, especially the preparation of the assessments, such as the socio-economic assessment. The submitter
of the dossier is highly dependent on data that is available from interested parties, as it seems to be impossible to
carry out such an assessment from scratch within a year [16]. The content and format of the dossier clariﬁes that
the objectives of REACH —human health and environmental protection on one side, and regulation of the internal
market on the other side— go hand in hand. The free movement of substances and products is an essential aspect in
the drafting of the restriction proposal, the actual amendment. Even the abundance of scientiﬁc data on hazards and
environmental fate does not guaranty regulatory measures: the restriction must also be justiﬁed on the basis of the
socio-economic assessment. The EC Study on Microplastics strikingly points out that economic considerations may
substantially aﬀect the justiﬁcation for restrictions as the costs aspects put a heavy weight in the balancing act [3].
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In the case of insuﬃcient scientiﬁc data, it seems that the precautionary principle does not play a signiﬁcant role
in the restriction procedure, even though it is part of the objectives of REACH. It is presumed that data gaps would
rather lead to “less than more” justiﬁcation of a restriction. For the restriction dossier on microplastics is therefore
of utmost importance that all available evidence is provided. When less data is available, restriction seems to be less
likely.
My ﬁnal remark concerns the importance of political will. Plastic pollution has recently drawn a lot of public and
political attention and the momentum for further regulation of plastics is there [4]. In the end, it is up to the European
Commission, together with the Council and the European Parliament, to make the ﬁnal decision on a restriction on
microplastics.
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